908 Devices Inc.·4

Jul 2, 4:15 PM ET

Brown Christopher D. 4

4 · 908 Devices Inc. · Filed Jul 2, 2026

Research Summary

AI-generated summary of this filing

Updated

908 Devices (MASS) Director Christopher D. Brown Sells 20,000 Shares

What Happened
Christopher D. Brown, a director of 908 Devices, sold 20,000 shares in an open-market transaction on June 30, 2026. The weighted average sale price was $8.84 per share, for total proceeds of approximately $176,800. The sale was reported on Form 4 filed July 2, 2026 and is coded as a sale (S), which is typically routine rather than a purchase signal.

Key Details

  • Transaction date: 2026-06-30 (reported 2026-07-02). Filing appears timely (filed within typical Form 4 deadlines).
  • Price: weighted average $8.84; individual trade prices ranged from $8.61 to $8.95.
  • Shares sold: 20,000; proceeds ≈ $176,800.
  • Shares owned after transaction: not specified in the provided filing excerpt.
  • Footnotes: F1 — sale executed under a Rule 10b5-1 trading plan adopted Nov 24, 2025. F2 — price is a weighted average; the filer can provide the breakdown of the number of shares sold at each price within the $8.61–$8.95 range on request.
  • Transaction code: S = Sale.

Context
Sales under a Rule 10b5-1 plan are pre-scheduled trades and are commonly used by insiders to sell shares without active trading decisions at the time of sale. Such sales are factual disclosures of insider activity and do not, by themselves, indicate the insider’s current view of the company’s prospects.

Insider Transaction Report

Form 4
Period: 2026-06-30
Transactions
  • Sale

    Common Stock

    [F1][F2]
    2026-06-30$8.84/sh20,000$176,800845,559 total
Footnotes (2)
  • [F1]This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2025.
  • [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.61 to $8.95 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Signature
/s/ Mark S. Levine, Attorney-in-Fact|2026-07-02

Documents

1 file
  • 4
    form4-07022026_040710.xmlPrimary